ERBB2 and breast cancer: Functional cross talks between the AR and HER2 signalling pathways in MDA-MB-453 and SUM-190 breast cancer cell have considerable similarities to prostate cancer cell lines suggesting an oncogenic potential of AR in ER–/AR+ breast cancers [11,16].